ANTITUMOR ACTIONS OF INTERFERONS - DIRECT, INDIRECT, AND SYNERGY WITH OTHER TREATMENT MODALITIES

被引：18

作者：

TYRING, SK ^{[1
]}

机构：

[1] UNIV TEXAS,MED BRANCH,DEPT MICROBIOL,GALVESTON,TX 77550

来源：

INTERNATIONAL JOURNAL OF DERMATOLOGY | 1987年 / 26卷 / 09期

关键词：

D O I：

10.1111/j.1365-4362.1987.tb02304.x

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：549 / 556

页数：8

共 97 条

[1]

BALL LA, 1982, TEX REP BIOL MED, V41, P487

[2]

BASHAM TY, 1983, J IMMUNOL, V130, P1492

[3] INTERFERON ENHANCES ANTIBODY-DEPENDENT CELLULAR CYTO-TOXICITY WHEN SUBOPTIMAL CONCENTRATIONS OF ANTIBODY ARE USED [J].

BASHAM, TY ;

SMITH, WK ;

MERIGAN, TC .

CELLULAR IMMUNOLOGY, 1984, 88 (02) :393-400

[4]

BENNETT CL, 1986, CANCER TREAT REP, V70, P1081

[5] PURIFIED HUMAN IMMUNE INTERFERON HAS MORE POTENT ANTICELLULAR ACTIVITY THAN FIBROBLAST OR LEUKOCYTE INTERFERON [J].

BLALOCK, JE ;

GEORGIADES, JA ;

LANGFORD, MP ;

JOHNSON, HM .

CELLULAR IMMUNOLOGY, 1980, 49 (02) :390-394

[6]

Borden E C, 1984, Cancer, V54, P2770, DOI 10.1002/1097-0142(19841201)54:2+<2770::AID-CNCR2820541425>3.0.CO

[7]

2-0

[8] EVIDENCE THAT TYPE-I AND TYPE-II INTERFERONS HAVE DIFFERENT RECEPTORS [J].

BRANCA, AA ;

BAGLIONI, C .

NATURE, 1981, 294 (5843) :768-770

[9]

BRENNING G, 1985, SCAND J HAEMATOL, V35, P543

[10] REVERSIBILITY OF THE TRANSFORMED AND NEOPLASTIC PHENOTYPE .1. PROGRESSIVE REVERSION OF THE PHENOTYPE OF X-RAY-TRANSFORMED C3H-10T1/2 CELLS UNDER PROLONGED TREATMENT WITH INTERFERON [J].

BROUTYBOYE, D ;

GRESSER, I .

INTERNATIONAL JOURNAL OF CANCER, 1981, 28 (02) :165-173

← 1 2 3 4 5 6 7 8 9 10 →